Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 306.34 K237.78 K236 K241.14 K252.72 K1.11 M 1.84 M Research & development —————— — Operating income -306.34 K-237.78 K-236 K-241.14 K-252.72 K-1.11 M -1.84 M Non-Operating Income, Total 1.49 M1.87 M1.92 M1.8 M1.45 M1.68 M 6.85 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.49 M1.87 M1.92 M1.8 M1.45 M1.68 M 6.85 M Unusual income/expense —————— — Pretax income 1.18 M1.63 M1.68 M1.56 M1.2 M577.12 K 5.02 M Equity in earnings —————— — Taxes 000000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.18 M1.63 M1.68 M1.56 M1.2 M577.12 K 5.02 M Discontinued operations —————— — Net income 1.18 M1.63 M1.68 M1.56 M1.2 M577.12 K 5.02 M Dilution adjustment 14.69 M1.87 M1.91 M1.79 M1.45 M1.68 M 6.84 M Preferred dividends 14.69 M1.87 M1.91 M1.79 M1.45 M1.68 M 6.84 M Diluted net income available to common stockholders 1.18 M1.63 M1.68 M1.56 M1.2 M577.12 K 5.02 M Basic earnings per share (Basic EPS) 0.050.060.070.070.050.02 0.21 Diluted earnings per share (Diluted EPS) 0.050.070.060.070.050.02 0.2 Average basic shares outstanding 14.34 M16.95 M17.47 M17.73 M18.49 M18.49 M — Diluted shares outstanding 14.34 M16.95 M17.47 M17.73 M18.49 M18.49 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —